Fund
Sincere thanks to the following for support of the Doerksen research group!

Research Support (as PI)

  • "Computational studies on manzamine inhibition of GSK-3beta and CDK5 for treatment of neuroinflammation." Robert J. Doerksen (PI); University of Mississippi's Center of Research Excellence in Natural Products Neuroscience (CORE-NPN) Small Grants Program (2007-2009)
  • "Rational Computer-Aided Drug Design for Glycogen Synthase Kinase-3 Inhibition" Robert J. Doerksen (PI); American Association of Colleges of Pharmacy (AACP) New Investigators Program (2007-2008)
  • "Uninterruptible Power Supplies for Continuous, Safe Operation of Research Computers" Robert J. Doerksen (PI); University of Mississippi Ole Miss Partners Program Grant (12/2006-6/2007)
  • "Network-accessible computer storage device for computationally-intensive medicinal chemistry research" Robert J. Doerksen (PI); Ole Miss Associates - Partners Program Grant, University of Mississippi (2005-2006)
  • "Ab initio Car-Parrinello QM/MM molecular dynamics study of the active site and catalytic functioning of biliverdin reductase" Robert J. Doerksen (PI); Faculty Research Program, University of Mississippi (1/2005-1/2006)
  • "Compiler for New Linux Computer Cluster" Robert J. Doerksen (PI); University of Mississippi Ole Miss Partners Program Grant (11/2004-11/2005)
  • Start-up funds from University of Mississippi; Robert J. Doerksen (PI); from School of Pharmacy, Research Institute for Pharmaceutical Science and Department of Medicinal Chemistry (2004-~2007)

Research Support (Co-PI or Co-investigator)

  • "Innovations through Computational Sciences" Colin G. Scanes, Sandra H. Harpole (PI's); National Science Foundation EPS-0556308; (5/1/2006-4/30/2009)
  • "Development and Testing of New Antimalarial Drugs" Mitchell A. Avery (PI); Centers for Disease Control and Prevention; (8/1/2006-7/31/2007)

Prior Support

  • "Rational Design of Novel Drugs for the Treatment of Emerging Infectious Diseases" Mitchell A. Avery (PI); Centers for Disease Control and Prevention; (9/30/2006-9/29/2007)
  • "Entrepreneurial Research and Education at the Interface of Polymers and Medicinal Chemistry" Lon J. Mathias (PI); National Science Foundation - Division of Graduate Education (DGE), Integrative Graduate Education and Research Traineeship (IGERT); DGE 0333136; (8/1/2004-9/31/2008)
  • "Rational Design of Novel Drugs for the Treatment of Emerging Infectious Diseases" Mitchell A. Avery (PI); Centers for Disease Control and Prevention U50/CCU423310-02; (9/15/2005-9/14/2006)
  • "Development and Testing of New Antimalarial Drugs" Mitchell A. Avery (PI); Centers for Disease Control and Prevention U01/CI000211-02; (8/1/2005-7/31/2006)
  • "Development and Testing of New Antimalarial Drugs" Mitchell A. Avery (PI); Centers for Disease Control and Prevention UR3/CCU418652-02; (8/1/2004-7/31/2005)

Travel Support

  • Travel Support for Robert J. Doerksen and group members to attend the 15th Conference on Current Trends in Computational Chemistry, Jackson, MS, November 3-4, 2006: Department of Medicinal Chemistry, University of Mississippi
  • Travel Support for Robert J. Doerksen to attend the 229th American Chemical Society National Meeting, San Diego, CA, March 13-17, 2005; support from: Michael Klein 65th Birthday Symposium; School of Pharmacy, University of Mississippi; Office of Research and Sponsored Programs, University of Mississippi
  • Travel Support for Robert J. Doerksen to attend the 13th Conference on Current Trends in Computational Chemistry, Jackson, MS, November 11-13, 2004: Office of Research and Sponsored Programs, University of Mississippi

Google | Web-mail | MyOlemiss
recently updated by Kitae Myoung